0 reactions
indianmarketgrid The action stops new-patient use and sales while authorities review concerns about the principal study behind the rare-disease medicine’s approval.
READ FULL ANALYSIS MEMBER ANALYSIS
THE IMG COMMUNITY
Market insights. Fresh perspectives. Your conversation.
indianmarketgrid The action stops new-patient use and sales while authorities review concerns about the principal study behind the rare-disease medicine’s approval.